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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Pertussis has been considered a vaccine-preventable “child-
hood disease”, but a shift in age distribution has been reported worldwide. We conducted a
seroepidemiological study in 2013 in Taiwan to elucidate the seroprevalence of pertussis
among elementary school children.
Methods: With a multilevel randomized method, which included 14 variables (4 population var-
iables, 4 socio-educational variables, and 6 medical facilities’ variables), the 29 executive dis-
tricts of New Taipei City, Taiwan, were categorized into five strata. From each stratum, the
number of school children as well as the number of elementary schools were proportionally
selected. Enzyme immunoassay was applied for pertussis immunoglobulin-G measurement.
Results: A total of 936 children from 14 schools were recruited. Most participants (98.89%)
received at least three doses of acellular diphtheria-tetanus-pertussis vaccine. The overall
seropositive rate for pertussis was 33.97%. The seropositive rate was highest for students in
Grade 1 (49.36%) and then declined with time, except for Grade 6 students. Students from
Grade 1 to Grade 4 had a significant higher seropositive rate (37.18% vs. 27.56%, p Z 0.002)
than those from Grade 5 to Grade 6, but a lower geometric mean titer (18.71 NovaTec Unit/
mL vs. 20.04 NovaTec Unit/mL, p Z 0.20). For the class grades, geometric mean titers were
positively correlated with seroprevalence (p < 0.005).
Conclusion: Currently, almost one-third of elementary school children in Taiwan were seropos-
itive for pertussis, a rate lower than expected. Seroprevalence declined with increasing classof Pediatrics, Chang Gung Children’s Hospital, Number 5, Fu-Hsin Street, Kweishan 333, Taoyuan,
g.tw (Y.-C. Huang).
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adequate protection for children against pertussis.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Pertussis is a highly contagious acute respiratory tract disease
caused by Bordetella pertussis, an exclusive human path-
ogen. Characterized by paroxysmal severe coughing spells,
pertussis sometimes causes severe complications in infants
and young children including pneumonia, seizure, encepha-
lopathy, and even death.1 Despite progress in vaccinations,
pertussis remains one of the top 10 causes of deathworldwide
in childhood, accounting for 30,000,000e50,000,000 cases
and nearly 300,000 deaths in children every year.2 So far,
breakthrough diseases in cycles were still observed every 3e5
years even in vaccinated populations.3,4
In Taiwan, whole-cell diphtheria-tetanus-pertussis vac-
cines had been offered to children free of charge at 2
months, 4 months, 6 months, and 18 months of age since
1954, based on the national immunization program. The
incidence of reported pertussis cases per year has declined
significantly thereafter from 77 cases per million in 1955 to
less than one case per million in 1970, and this low inci-
dence was retained from 1971 to 1991 before an unex-
pected outbreak developed in 1992.5 Two types of acellular
diphtheria-tetanus-pertussis (DTaP) vaccines from Kaket-
suken (Chemo-Sero-Therapeutic Research Institute),
Okubo, Kumamoto, Japan [DPT “KAKETSUKEN” SYRINGE
consisting PtxS1B and filamentous hemagglutinin (FHA)] and
SmithKline Beecham Biologicals (became GlaxoSmithKline
Biologicals since 2000), Rixensart, Belgium (INFANRIX con-
sisting of PtxS1B, FHA, and Prn1 from the Tohama strain)
were licensed for use since 1996 and 1998, respectively, at
the patient’s own expense. The DTaP vaccine was later
universally substituted by the diphtheria and tetanus toxoid
with acellular pertussis, Haemophilus influenzae type b,
and inactivated polio vaccine; INFANRIX-IPV þ Hib consist-
ing pertussis toxin (PT), FHA, and pertactin from Glax-
oSmithKline Biologicals, Rixensart, Belgium, or PEDIACEL
consisting PT, FHA, pertactin, and fimbrial agglutinogens
2 þ 3 from Sanofi Pasteur, Toronto, Ontario, and included in
the expanded program on immunization (EPI), since 2010.
In addition, since March, 2009 the reduced dose tetanus,
diphtheria, and acellular pertussis vaccine (Tdap; ADACEL
consisting PT, FHA, pertactin, fimbrial agglutinogens 2 þ 3
from Sanofi Pasteur, Toronto, Ontario) was introduced into
EPI as a booster for children from 5 years of age to
elementary school Grade 1.
Completion of at least three doses of acellular pertussis
vaccine was thought to result in higher efficacy in pre-
venting typical whooping cough and in preventing mild
pertussis disease, compared with administration of one to
two doses only.6 However, in children who completed five
doses of pertussis vaccine, pertussis was still observed in
older children, and the odds increased as the time since lasto C-C, et al., Seroepidemiology o
and Infection (2015), http://dx.DTap increased, suggesting waning protection despite the
five-dose-DTap schedule.7 An increase in yearly reported
pertussis cases of children aged 5e9 years was observed in
Taiwan recently, but both of their associated vaccination
status and seroepidemiologic information were lacking.5
The purpose of this study was to establish the seroepide-
miologic data of pertussis among children attending
elementary schools in New Taipei City, Taiwan, which
would be the pilot study of nationwide surveillance, and
would be provided as a reference of the national immuni-
zation program in Taiwan.
Methods
Ethics statement
The study proposal was reviewed and approved by the Insti-
tutional Review Board of Chang Gung Memorial Hospital,
Taoyuan, Taiwan in 2012. Informed consent in written form
was obtained from all participants, as well as their guardians.
Study populations
A cross-sectional survey of anti-B. pertussis immunoglobulin
(Ig)-G antibodies in the population of elementary school
children in New Taipei City was conducted from September
2012 to June 2013. New Taipei City comprises 29 adminis-
trative districts and is the second largest specialmunicipality
in northern Taiwan. A total of 225,234 pupils resided in this
city,which accounted for 16.5% of all primary school children
in Taiwan in 2012. A multistage stratified method with
probability proportional to size sampling was employed to
obtain samples. Thewhole 29 administrative districts of New
Taipei City were classified into five strata based on 14 vari-
ables, which included four demographic variables [popula-
tion density (persons/km2), proportion of population older
than 65 years, younger than 15 years, and younger than 6
years], four socio-educational variables (number of low-
income households per 10,000 people, number of near-poor
households per 10,000 people, proportion of agriculture
population, proportion of population with college degree or
above), and six medical facilities’ variables (number of
physicians per 10,000 people, number of nursing staffs per
10,000 people, number of nursing staffs in health centers per
10,000 people, number of medical personnel in health cen-
ters per 10,000 people, number of staffs in health centers per
10,000 people). Elementary schools in each stratum were
selectedwith selection probability proportional to their size.
One class was drawn from each grade in a sampled school,
that is, six classes in total were drawn from each sampled
school. In each selected school, the number of students inf pertussis among elementary school children in northern Taiwan,
doi.org/10.1016/j.jmii.2015.07.006
Table 1 Seroprevalence among 936 elementary school
children in five strata.a
School*
(Administrative district)
Participant
No.
Positive cases
N (%) GMTb
Stratum 1 576 205 (35.59) 10.55
Zhong-Shan (Ban-Qiao) 96 39 (40.63) 11.22
San-Zhong (San-Zhong) 96 39 (40.63) 12.22
Zhong-Gang (Xin-Zhuang) 96 37 (38.54) 11.11
Lu-Zhou (Lu-Zhou) 96 32 (33.33) 9.77
Ji-Mei (San-Zhong) 96 29 (30.21) 9.57
Ju-Guang (Ban-Qiao) 96 29 (30.21) 9.38
Stratum 2 120 41 (34.17) 9.28
Cheng-Fu (San-Xia) 60 18 (30) 8.95
Xin-Xing (Dan-Shui) 60 23 (38.33) 9.62
Stratum 3 72 21 (29.17) 9.06
Jin-Mei (Jin-Shan) 36 7 (19.44) 7.94
Jin-Long (Xi-Zhi) 36 14 (38.89) 10.17
Stratum 4 144 44 (30.56) 9.64
Gan-Yuan (Shu-Lin) 72 28 (38.89) 11.68
Wu-Gu (Wu-Gu) 72 16 (22.22) 7.6
Stratum 5 24 7 (29.17) 9.21
Shi-Ding (Shi-Ding) 12 2 (16.67) 7.67
Shuang-Xi (Shuang-Xi) 12 5 (41.67) 10.76
Total 936 318 (33.97)
a The five strata were classified according to 14 variables (see
text).
b GMT: geometric mean titer, in NovaTec unit/mL.
*There was no significant difference among schools (p Z 0.16)
and strata (p Z 0.66).
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to their size. Finally, students were randomly selected in
each class. Accordingly, 558 studentswould be selected from
six schools in Stratum 1, 130 students from two schools in
Stratum 2, 66 students from two schools in Stratum 3, 140
students from two schools in Stratum 4, and seven students
from two schools in Stratum 5. In total, at least 901 students
should be obtained. Subsequently, we planned to recruit a
total of 936 students from the selected schools. Blood was
drawn from selected students for the serologic tests of
pertussis. All participants were relatively healthy without
acute illness while blood samples were drawn between
February 2013 and April 2013. Past medical history was
gathered via a questionnaire from each participant and the
pertussis vaccination status of each participantwas provided
by the Centers for Diseases Control of Taiwan (CDC-Taiwan)
and the student vaccination record in each school.
Determination of pertussis-specific antibodies
Sera were stored at 20C before measurments. Enzyme
immunoassay (NovaLisa Bordetella pertussis IgG/IgA ELISA,
NovaTec Immundiagnostica GmbH, Dietzenbach, Germany)
was applied for the qualitative determination of IgG-class
antibodies against B. pertussis in the participants’ sera.
Sera were tested following the directions of the manufac-
turers. Based on the instructions of NovaLisa, the antibody
titers were acquired using NovaTec Units (NTU). A NTU was
defined as the mean sample absorbance value  10/cut-off
value. The results were considered positive for titers >11
NTU, negative for titers below 9 NTU, and equivocal be-
tween 9 NTU and 11 NTU.
Statistical analysis
Based on timing of blood sampling and age on school
enrollment, students in Grade 1 were mostly born between
September 2005 and August 2006; students in Grade 2 were
born between September 2004 and August 2005, and so on.
Nine hundred and twenty-eight students out of 936 (99.15%)
students were in the correct age group of their Grade levels
during the survey period. As Tdap was included in EPI as a
booster for children >5 years since 2009 in Taiwan, all the
students from Grade 1 to Grade 4 were supposed to have
received a further booster vaccine against pertussis.
Pertussis-specific antibody titers were presented as geo-
metric mean titers (GMTs). Differences in seropositive
percentages between different groups were tested using
the Chi-square test. The unpaired t test was used to
compare the statistic deviances between GMT levels in
different Grade. The trend of decreasing GMT was assessed
using a linear regression method. Data analyses were per-
formed using SPSS software version 20.0 (SPSS Inc., Chi-
cago, Illinois, United States). A p value < 0.05 was
considered statistically significant.
Results
A total of 936 students from 14 elementary schools were
recruited in this study for serologic testing of pertussis, of
whom 48.29% were boys. Among the 936 children, 318 werePlease cite this article in press as: Kuo C-C, et al., Seroepidemiology o
Journal of Microbiology, Immunology and Infection (2015), http://dx.positive for anti-B. pertussis IgG antibody, with an overall
seropositive rate of 33.97%. Seropositive rates were not
significantly different between genders. Among schools,
seropositive rates varied from 16.67% (Shi-Ding elementary
school, Shi-Ding district) to 41.67% (Shuang-Xi elementary
school, Shuang-Xi district), both schools in Stratum 5
(p Z 0.18). The seropositive rate was below 20% for stu-
dents in two schools (Jin-Mei elementary school, Jin-Shan
district; Shi-Ding elementary school, Shi-Ding district).
Stratum-wisely, seropositive rates ranged from 29.17% for
the Stratum 3 to 35.59% for Stratum 1. There was no sta-
tistically significant difference in seropositive rates either
among schools (p Z 0.16) or among strata (p Z 0.66).
Details are shown in Table 1.
Among 936 participants, 34 with unclear vaccine status
were thus excluded for further analyses of the association
between vaccine doses and seroprevalence. Eight hundred
and ninety-two (98.89%) participants received at least
three doses of pertussis vaccine, and the seropositive rate
ranged from 30.77% to 37.5%. In this population, 576
(64.57%) received a Tdap booster vaccine at the age of 5
years and had a higher seropositive rate than those who did
not (36.63% vs. 31.65%, pZ 0.07). Detailed data are shown
in Table 2.
Grade-specific pertussis seroprevalence and GMTs are
illustrated in Figure 1. The seropositive rate was highest at
49.36% for students in Grade 1, decreased to 39.1% for
Grade 2 (pZ 0.04), and thereafter decreased to a nadir of
25% for Grade 4 and Grade 5. The seropositivity for studentsf pertussis among elementary school children in northern Taiwan,
doi.org/10.1016/j.jmii.2015.07.006
Table 2 Association between vaccination doses and geometric mean titrea in 902b children.
4 doses þ 1 booster 4 doses 3 doses þ 1 booster 3 doses 1 or 2 doses þ 1 booster 1 or 2 doses
Participant No. 544b 303b 32b 13b 6 4
Positive
N (%) 199 (36.58) 96 (31.68) 12 (37.5) 4 (30.77) 1 (16.67) 0
GMTc 19.09 19.75 14.41 23.25 12.8 N/A
Equivocal No. 25 11 0 0 0 0
Negative No. 320 196 20 9 5 4
a Among 936 participants, 34 with one or two doses of pertussis vaccine but booster status unclear were excluded.
b Eight hundred and ninety-two (98.89%) participants received more than three doses of pertussis vaccine, among them 576 with a
Tdap booster had a higher seropositive rate (36.63% vs. 31.65%, pZ 0.16); compared with their nonboostered group, both “4 doses þ 1
booster” (pZ 0.17) and “3 doses þ 1 booster” (pZ 0.74) possessed higher seropositive, insignificant statistic difference between the “4
doses þ 1 booster” and “3 doses þ 1 booster” groups (p Z 0.92) was observed.
c GMT: geometric mean titer, in NovaTec unit/mL.
N/A Z not available.
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reach statistical significance (30.13% vs. 25%, p Z 0.18).
Individuals from Grade 1 to Grade 4 had a significant higher
seropositive rate (37.18% vs. 27.56%, pZ 0.002) than those
from Grade 5 to Grade 6, but a lower anti-B. pertussis IgG
GMT (18.71 NTU/mL vs. 20.04 NTU/mL, p Z 0.20) for
seropositive participants. Similar to seropositivity, anti-B.
pertussis IgG GMTs of the students decreased significantly
from 13.37 NTU/mL for students in Grade 1 to a nadir of
7.76 NTU/mL for Grade 4, and then increased to 9.7 NTU/
mL for Grade 6. No statistically significant difference was
observed between GMTs for students in Grade 5 and in
Grade 6 (p Z 0.12). Seropositive rates were positively
correlated with anti-B. pertussis IgG GMTs (p < 0.005).
Discussion
To the best of our knowledge, this is the first cross-sectional
study applying a multilevel randomized sampling method toFigure 1. Grade-specific pertussis seropositive rates and
change of geometric mean titers, in NovaTec unit/mL. The
seropositive rate declined to a nadir at Grade 4 and Grade 5, but
then rose at Grade 6. Both the seropositive rate (p Z 0.31) and
the geometric mean titers (pZ 0.03) were higher at Grade 6 than
at Grade 4. The seropositive rate was positively correlated with
anti-Bordetella pertussis immunoglobulin-G titers (p < 0.005).
GMT Z geometric mean titers; NTU Z NovaTec unit.
Please cite this article in press as: Kuo C-C, et al., Seroepidemiology o
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elementary school children. This study disclosed a sero-
positive rate of 33.97% for pertussis among elementary
school children in New Taipei City in spring time, 2013. All
of the seropositive rates, either stratified by strata,
schools, or Grades, were <50%.
Because of mild symptoms or atypical manifestations,
laboratory confirmation is usually crucial in the diagnosis of
pertussis, which includes DNA detection with polymerase
chain reaction or measuring B. pertussis-specific antibodies
by enzyme-linked immunosorbent assay (ELISA).8,9,10 ELISAs
detecting antibodies to Bordetella antigens were devel-
oped during the acellular vaccine trials, and were
employed in seroepidemiological studies.11 Most of the
ELISAs used purified antigens, of which only PT is specific
for B. pertussis, although use of mixed antigens has been
reported. Previous studies have focused mainly on anti-B.
pertussis IgG antibodies, since the role of IgA antibodies
was unclear in the vaccinated population.8,12 Commercial
kits measuring IgA have been reported to have sensitivities
ranging between 0.53 and 0.73, with specificities ranging
between 0.67 and 0.94, indicating probable limited diag-
nostic value of IgA measurement in clinical circum-
stances.13 Kits using PT as an antigen showed linearity
compared with the World Health Organization reference
preparation, whereas ELISA kits using mixed antigens
showed no linear correlation.13 In this study, we applied the
NovaLisa Bordetella Pertussis IgG/IgA ELISA kit, which used
PT and FHA as antigens. NovaLisa ELISA kit was reported to
have a sensitivity up to 95% detecting pertussis IgG. Despite
that the fact that its specificity was only 54% as demon-
strated by Riffelmann et al,13 NovaLisa Pertussis IgG/IgA
ELISA was considered capable of meeting our seroepide-
miologic purpose and producing reliable results.
Lai et al14 demonstrated that in a pediatric population
highly immunizedwithdiphtheria and tetanus toxoid andpolio
vaccines in Singapore, seroprevalence of pertussis waned
rapidly over time compared with that of concurrently vacci-
nated diphtheria and poliovirus.14 Their study also remarked
that the prevalence of pertussis IgG antibody declined with
time since the last pertussis vaccine, and remained only at
w50% in those who last received pertussis vaccine 4 years
ago,which suggested the need of a booster dose at adolescent
stage. The rapid waning of protection from vaccination wasf pertussis among elementary school children in northern Taiwan,
doi.org/10.1016/j.jmii.2015.07.006
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in the United States suggested that assuming 85% efficacy,
DTaP provided an average of only 3 years of protection, and
the differencebetween regimens (3-dose vs. 5-dose schedule)
did not significantly affect the annual odds of pertussis, which
was actually higher in older age group.15
As stated above, Tdap was included in EPI as a booster for
children>5 years since 2009 in Taiwan, hence all the students
from Grade 1 to Grade 4 in our cross-sectional study, but not
for those from Grade 5 to Grade 6, were supposed to have
received a further booster vaccine against pertussis. Ac-
cording to thedata fromCDC-Taiwan, thevaccination rate for
the third and fourth dose of DTaP-Hib-IPV reached 96% and
94%, respectively, and the vaccination rate for Tdap was
>97% by 2011. Despite the massive administration of
pertussis vaccine, the seropositive rate was still <50%, even
in those receiving their Tdap booster vaccines within just 1
year prior to this study. Seroprevalence in students from
Grade 1 to Grade 4 declined with time, the students in Grade
5 had the same seroprevalence as that for Grade 4, and stu-
dents in Grade 6 even had a higher seropositive rate
(pZ 0.31) and higher GMTs (pZ 0.03) than those in Grade 4
(Figure 1). The overall low seroprevalencemay be associated
with the transition of EPI fromwhole-cell vaccine to acellular
vaccine. Gambhir et al16 indicated that the priming acellular
pertussis vaccine may have lower efficacy and shorter dura-
tion of protection than the whole-cell vaccine. Sheridan
et al17 also illustrated the different effectiveness of whole-
cell and acellular vaccine. But the serial inter-grade
decrease of GMT levels from Grade 1 to Grade 4 with an in-
verse increase from Grade 5 to Grade 6 could not be
explained. The participants in this study might choose to
receive the acellular vaccine as the primary series of vacci-
nation at their own expense instead of thewhole-cell vaccine
included in the EPI, but we did not have enough information
to conclude that the high-grade students had a higher rate of
vaccination with whole-cell vaccine, and thus developed a
higher GMT level. As protection from the vaccine waned over
time, older children were prone to develop break-through
pertussis infections. In addition to the lack of Tdap booster
administration, circulating bacteria evolved away from vac-
cine antigens might also increase the chance of natural B.
pertussis infection among high-grade students since their last
vaccination against pertussis, resulting in higher antibodies.
Pertussis was thought to be a vaccine-preventable
childhood disease.18,19 After the initiation of massive
vaccination in many countries, the disease prevalence
decreased significantly but a shift in the age distribution of
this disease has been reported in Japan,20 United
States,21,22 Canada,23 Australia,24 China,25 and Korea.26 Lin
et al5 showed a significant upward trend in the pertussis
incidence in adolescents aged 10e14 years in Taiwan be-
tween 1993 and 2004.5 According to up-to-date surveillance
data from CDC-Taiwan, infants aged <1 year (n Z 240,
44.28%) still accounted for the highest proportion of all
reported cases in the past decade (between 2005 and
2014), followed by adolescents aged 10e14 years (n Z 96,
17.71%), and adults aged 35e39 years (n Z 31, 5.72%).
The shift in age distributionmay be contributed bymultiple
factors. Firstly, massive vaccination not only protected
vaccinated population from pertussis, but also made the
vaccinated less exposed to wild-type B. pertussis booster.Please cite this article in press as: Kuo C-C, et al., Seroepidemiology o
Journal of Microbiology, Immunology and Infection (2015), http://dx.Secondly, vaccine-induced immunity against pertussis was
reported to wane 4e12 years after the last vaccination.27 This
study revealed that anti-B. pertussis antibodies in Taiwanese
elementary school children may have decreased faster than
we expected. Based on the model by Lai et al,14 the seropre-
valence threshold should achieve at least 90e95% to establish
herd immunity against pertussis. With such universally low
seroprevalence among the participants in this study, the cur-
rent immunization program in Taiwan may be incapable of
achieving adequate herd immunity in elementary school chil-
dren, and outbreaks of pertussis among school children might
take place under such a circumstance. Thirdly, the upward
trend in adolescents and adults might be the tip of the
iceberg,28 because physicians in Taiwan are unfamiliar with
pertussis and thus most pertussis cases were under-diagnosed
or undiagnosed.29 Atypical symptoms, lack of seeking medical
evaluation, and misperception that pertussis remained a
“childhood disease” all lead to under-diagnosis, and enabled
the infected adolescents and adults to transmit pertussis to
younger children with possible severe complications,30 espe-
cially in those who had not completed their vaccinations.
For the waning antibodies from vaccination, immuniza-
tion for adolescents against pertussis was recommended in
the United States, Canada, and European regions.29,31,32
Routine use of acellular pertussis vaccine was protective
among adolescents and adults, and might reduce the
overall disease burden and transmission to children.33 As
more effective and less reactogenic new vaccines are un-
likely to be commercially available in the following decade,
it has also been suggested that a universal vaccination in all
age groups at frequent intervals is required to develop herd
immunity,34 although the optimal timing and frequency of
booster doses are uncertain at the moment.17 Seroepi-
demiology status for pertussis among Taiwanese adoles-
cents and adults may be important to determine an
endemic disease burden and to optimize an immunization
program with the Tdap booster.
In 2013, only one-third of elementary school children in
New Taipei City, Taiwan, were seropositive for pertussis, a
rate lower than expected. Seroprevalence in students from
Grade 1 to Grade 4 declined with time but was still signif-
icantly higher than that for Grade 5 and Grade 6. The
current national immunization program may not provide
adequate protection for children against pertussis, and a
booster vaccine administered at regular intervals from
adolescent stage may be beneficial to ensure herd effects
and decrease the burden of illness.Conflicts of interest
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